Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

TOKYO, May 23, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society

Related Keywords

Japan , Hangzhou , Zhejiang , China , Chicago , Illinois , United States , Canada , Tokyo , Kanagawa , Fukushima , American , , American Society Of Clinical Oncology , Eisai Co Ltd , Bliss Biopharmaceutical Hangzhou Co Ltd , Merck Co Inc , Merck Sharp Dohme , Biolab Co Ltd , Public Relations Department , Clinical Oncology , Annual Meeting , New Window , Takashi Owa , Chief Scientific Officer , Senior Vice President , Bliss Biopharmaceutical , Zhejiang Province , Deep Human Biology Learning , Merck Sharp , Progress Submission , Relations Department , Ihr Portfolio ,